Peter Behner

CIK: 0001851420

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)11 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

INKT

MiNK Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (11 total)

INKT
MiNK Therapeutics, Inc.
Sep 1, 2026
Award(A)
Direct
1.5K shares at avg. $10.95$16K
INKT
MiNK Therapeutics, Inc.
Jun 1, 2026
Award(A)
Direct
1.3K shares at avg. $12.38$16K
INKT
MiNK Therapeutics, Inc.
Mar 2, 2026
Award(A)
Direct
1.5K shares at avg. $10.90$16K
INKT
MiNK Therapeutics, Inc.
Jan 2, 2026
Award(A)
Stock Option (Right to Buy)
Direct
5.4K shares-
INKT
MiNK Therapeutics, Inc.
Dec 1, 2025
Award(A)
Direct
1.5K shares at avg. $11.09$16K
INKT
MiNK Therapeutics, Inc.
Sep 9, 2025
Award(A)
Stock Option (Right to Buy)
Direct
3.2K shares-
INKT
MiNK Therapeutics, Inc.
Sep 2, 2025
Award(A)
Direct
1.2K shares at avg. $13.86$16K
INKT
MiNK Therapeutics, Inc.
Jun 2, 2025
Award(A)
Direct
2.3K shares at avg. $7.17$16K
INKT
MiNK Therapeutics, Inc.
Mar 3, 2025
Award(A)
Direct
1.8K shares at avg. $8.79$16K
INKT
MiNK Therapeutics, Inc.
Dec 1, 2024
Award(A)
Direct
21K shares at avg. $0.73$15K
INKT
MiNK Therapeutics, Inc.
Sep 3, 2024
Award(A)
Direct
18.8K shares at avg. $0.82$15K

		Type	Shares	Price		Ownership
Sep 1, 2026	INKT MiNK Therapeutics, Inc.	Award(A)	1,485	$10.95	$16,261	Direct
Jun 1, 2026	INKT MiNK Therapeutics, Inc.	Award(A)	1,313	$12.38	$16,255	Direct
Mar 2, 2026	INKT MiNK Therapeutics, Inc.	Award(A)	1,491	$10.90	$16,252	Direct
Jan 2, 2026	INKT MiNK Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	5,395	-	-	Direct
Dec 1, 2025	INKT MiNK Therapeutics, Inc.	Award(A)	1,466	$11.09	$16,258	Direct
Sep 9, 2025	INKT MiNK Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	3,225	-	-	Direct
Sep 2, 2025	INKT MiNK Therapeutics, Inc.	Award(A)	1,173	$13.86	$16,258	Direct
Jun 2, 2025	INKT MiNK Therapeutics, Inc.	Award(A)	2,267	$7.17	$16,254	Direct
Mar 3, 2025	INKT MiNK Therapeutics, Inc.	Award(A)	1,849	$8.79	$16,253	Direct
Dec 1, 2024	INKT MiNK Therapeutics, Inc.	Award(A)	20,987	$0.73	$15,321	Direct
Sep 3, 2024	INKT MiNK Therapeutics, Inc.	Award(A)	18,753	$0.82	$15,377	Direct

1-11 of 11 transactions

About Behner Peter

Behner Peter (SEC CIK 0001851420) files insider reports with the SEC as Director of MiNK Therapeutics, Inc. (INKT).

Signal8 holds 10 ownership filings by Behner Peter, all Form 4s, filed between Sep 5, 2024 and Sep 2, 2026. Those filings report 11 transactions, from Sep 3, 2024 to Sep 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Behner Peter's filings is in NEW YORK, NY.

Recent filings by Behner Peter

Sep 1, 2026: Grant or award of INKT shares (Form 4, code A).
Jun 1, 2026: Grant or award of INKT shares (Form 4, code A).
Mar 2, 2026: Grant or award of INKT shares (Form 4, code A).
Jan 2, 2026: Grant or award of INKT derivative securities (Form 4, code A).
Dec 1, 2025: Grant or award of INKT shares (Form 4, code A).

Other insiders filing for MiNK Therapeutics, Inc. (INKT)

Buell Jennifer, Chief Executive Officer
WIINBERG ULF, Director
Holcomb John Bradley, Director
Ryan Barbara, Director
Corvese Brian, Director
Orilall Melissa, Principal Financial Officer

How to read Form 4 transaction codes